
Next-Gen CAR T-Cell Therapy: Expanding Beyond Blood Cancers
Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of refractory or relapsed leukemia and hematologic malignancies, particularly over the past decade. Despite its unprecedented success, challenges regarding safety and efficacy, …